FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Henrik Borg

Research Profile

Chemicals & Drugs

Anatomy

Disorders

Geographic Areas

Sweden

Concepts & Ideas

Co-author Network

Publications

TOP 3
Bo Berger; Henrik Borg; Per Fernlund; Gunnar Stenström; Göran Sundkvist
Islet antibodies associated with pancreatic B-cell dysfunction at and 3 years after diagnosis of diabetes in subjects aged 35-64 years old: degree of impairment less severe than in those aged 0-34 years old.
E Bakhtadze; Henrik Borg; Gunnar Stenström; Per Fernlund; Hans J Arnqvist; A Ekbom-Schnell; Jan Bolinder; Jan W Eriksson; S Gudbjörnsdottir; Lennarth Nyström; L C Groop; Göran Sundkvist
HLA-DQB1 genotypes, islet antibodies and beta cell function in the classification of recent-onset diabetes among young adults in the nationwide Diabetes Incidence Study in Sweden.
Jan Bolinder; Per Fernlund; Henrik Borg; H J Arnqvist; Erik Björk; Göran Blohmé; Jan W Eriksson; L Nyström; Jan Ostman; Göran Sundkvist
Hyperproinsulinemia segregates young adult patients with newly diagnosed autoimmune (type 1) and non-autoimmune (type 2) diabetes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Henrik Borg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Bo Berger; Henrik Borg; Per Fernlund; Gunnar Stenström; Göran Sundkvist
Islet antibodies associated with pancreatic B-cell dysfunction at and 3 years after diagnosis of diabetes in subjects aged 35-64 years old: degree of impairment less severe than in those aged 0-34 years old.
Diabetic medicine : a journal of the British Diabetic Association 2006;23(11):1180-5.
2006: E Bakhtadze; Henrik Borg; Gunnar Stenström; Per Fernlund; Hans J Arnqvist; A Ekbom-Schnell; Jan Bolinder; Jan W Eriksson; S Gudbjörnsdottir; Lennarth Nyström; L C Groop; Göran Sundkvist
HLA-DQB1 genotypes, islet antibodies and beta cell function in the classification of recent-onset diabetes among young adults in the nationwide Diabetes Incidence Study in Sweden.
Diabetologia 2006;49(8):1785-94.
2005: Jan Bolinder; Per Fernlund; Henrik Borg; H J Arnqvist; Erik Björk; Göran Blohmé; Jan W Eriksson; L Nyström; Jan Ostman; Göran Sundkvist
Hyperproinsulinemia segregates young adult patients with newly diagnosed autoimmune (type 1) and non-autoimmune (type 2) diabetes.
Scandinavian journal of clinical and laboratory investigation 2005;65(7):585-94.
2004: Anna Schölin; L Björklund; Henrik Borg; Hans J Arnqvist; Erik Björk; Göran Blohmé; Jan Bolinder; Jan W Eriksson; S Gudbjörnsdottir; Lennarth Nyström; Jan Ostman; A F Karlsson; Göran Sundkvist
Islet antibodies and remaining beta-cell function 8 years after diagnosis of diabetes in young adults: a prospective follow-up of the nationwide Diabetes Incidence Study in Sweden.
Journal of internal medicine 2004;255(3):384-91.
2003: Henrik Borg; Hans J Arnqvist; Erik Björk; Jan Bolinder; Jan W Eriksson; Lennarth Nyström; Jan-Olof Jeppsson; Göran Sundkvist
Evaluation of the new ADA and WHO criteria for classification of diabetes mellitus in young adult people (15-34 yrs) in the Diabetes Incidence Study in Sweden (DISS).
Diabetologia 2003;46(2):173-81.
2002: Gunnar Stenström; Bo Berger; Henrik Borg; Per Fernlund; Janice S Dorman; Göran Sundkvist
HLA-DQ genotypes in classic type 1 diabetes and in latent autoimmune diabetes of the adult.
American journal of epidemiology 2002;156(9):787-96.
2002: Henrik Borg; C Marcus; S Sjöblad; Per Fernlund; Göran Sundkvist
Insulin autoantibodies are of less value compared with islet antibodies in the clinical diagnosis of autoimmune type 1 diabetes in children older than 3 yr of age.
Pediatric diabetes 2002;3(3):149-54.
2002: Henrik Borg; Anders Gottsäter; Per Fernlund; Göran Sundkvist
A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes.
Diabetes 2002;51(6):1754-62.
2001: Henrik Borg; Anders Gottsäter; M Landin-Olsson; Per Fernlund; Göran Sundkvist
High levels of antigen-specific islet antibodies predict future beta-cell failure in patients with onset of diabetes in adult age.
The Journal of clinical endocrinology and metabolism 2001;86(7):3032-8.
2001: Ulf Samuelsson; Göran Sundkvist; Henrik Borg; Per Fernlund; Johnny Ludvigsson
Islet autoantibodies in the prediction of diabetes in school children.
Diabetes research and clinical practice 2001;51(1):51-7.
2000: Henrik Borg; C Marcus; S Sjöblad; Per Fernlund; Göran Sundkvist
Islet cell antibody frequency differs from that of glutamic acid decarboxylase antibodies/IA2 antibodies after diagnosis of diabetes.
Acta paediatrica (Oslo, Norway : 1992) 2000;89(1):46-51.
1997: Henrik Borg; Per Fernlund; Göran Sundkvist
Protein tyrosine phosphatase-like protein IA2-antibodies plus glutamic acid decarboxylase 65 antibodies (GADA) indicates autoimmunity as frequently as islet cell antibodies assay in children with recently diagnosed diabetes mellitus.
Clinical chemistry 1997;43(12):2358-63.
1997: Henrik Borg; Per Fernlund; Göran Sundkvist
Measurement of antibodies against glutamic acid decarboxylase 65 (GADA): two new 125I assays compared with [35S]GAD 65-ligand binding assay.
Clinical chemistry 1997;43(5):779-85.